Recital 4, Regulation (EU) 2023/918

In forcesince 4 May 2023

Commission Implementing Regulation (EU) 2017/1527 [Commission Implementing Regulation (EU) 2017/1527 of 6 September 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances cyflufenamid, fluopicolide, heptamaloxyloglucan and malathion (OJ L 231, 7.9.2017, p. 3).] extends the approval period of the active substance fluopicolide until 31 May 2023.